The administration of istradefylline in focal cortical cerebral ischemia may be effective in countering the effects of upregulated A2AR expression subsequent to stroke damage, which contributes to increased neuroinflammation, neurodegeneration, and behavioral abnormalities in our in vivo focal cortical stroke model. This evidence concerns the gene ADORA2A and stroke disorder.